HMG-CoA

Results: 84



#Item
31XENICAL® (ORLISTAT) FOR HYPERCHOLESTEROLEMIA MEDICATIONS CRITERIA Pharmacology: Orlistat: Reverse lipase inhibitor that acts by inhibiting the absorption of dietary fats. Medication:

XENICAL® (ORLISTAT) FOR HYPERCHOLESTEROLEMIA MEDICATIONS CRITERIA Pharmacology: Orlistat: Reverse lipase inhibitor that acts by inhibiting the absorption of dietary fats. Medication:

Add to Reading List

Source URL: www.nhhealthyfamilies.com

Language: English - Date: 2014-09-11 16:49:00
32HMG-CoA Reductase Inhibitors (atorvastatin, fluvastatin, lovastatin, pravastatin, simvastatin, pitavastatin, rosuvastatin) and safety the risk of new onset diabetes/impaired glucose metabolism Agreed by PhVWP March 2012

HMG-CoA Reductase Inhibitors (atorvastatin, fluvastatin, lovastatin, pravastatin, simvastatin, pitavastatin, rosuvastatin) and safety the risk of new onset diabetes/impaired glucose metabolism Agreed by PhVWP March 2012

Add to Reading List

Source URL: www.hma.eu

Language: English - Date: 2012-04-03 07:14:37
33Microsoft Word - PRAVACHOL_E_PIL_11 Jan 2013_APP_DIST.doc

Microsoft Word - PRAVACHOL_E_PIL_11 Jan 2013_APP_DIST.doc

Add to Reading List

Source URL: www.bmscanada.ca

Language: English - Date: 2013-01-25 11:26:25
34Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index

Add to Reading List

Source URL: www.health.gov.on.ca

Language: English - Date: 2014-11-18 09:36:10
35Microsoft Word - CMDh-PhVWP-006-Rev0_2009 11

Microsoft Word - CMDh-PhVWP-006-Rev0_2009 11

Add to Reading List

Source URL: www.hma.eu

Language: English - Date: 2009-11-26 06:38:20
36Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCAD)

Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCAD)

Add to Reading List

Source URL: health.mo.gov

Language: English - Date: 2009-02-03 16:51:10
37Endocrinologic and Metabolic Drugs Advisory Committee  VYTORIN / ZETIA NDAs[removed]and[removed]James P. Smith, MD, MS Division of Metabolism and Endocrinology Products

Endocrinologic and Metabolic Drugs Advisory Committee VYTORIN / ZETIA NDAs[removed]and[removed]James P. Smith, MD, MS Division of Metabolism and Endocrinology Products

Add to Reading List

Source URL: www.fda.gov

Language: English
38Microsoft Word - PRAVACHOL_E_PM_11 Jan 2013_APP_DIST_CLN.doc

Microsoft Word - PRAVACHOL_E_PM_11 Jan 2013_APP_DIST_CLN.doc

Add to Reading List

Source URL: www.bmscanada.ca

Language: English - Date: 2013-01-25 11:24:03
39[removed]VYTORIN ® [removed]EZETIMIBE 10 MG/SIMVASTATIN 10 MG TABLETS)  VYTORIN ® 10/20

[removed]VYTORIN ® [removed]EZETIMIBE 10 MG/SIMVASTATIN 10 MG TABLETS) VYTORIN ® 10/20

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2009-03-31 14:10:08
403-Hydroxy-3-Methylglutaryl-CoA Lyase (HMG) Deficiency (metabolic condition: organic acid disorder) Also known as: •	 HMG-CoA lyase deficiency

3-Hydroxy-3-Methylglutaryl-CoA Lyase (HMG) Deficiency (metabolic condition: organic acid disorder) Also known as: • HMG-CoA lyase deficiency

Add to Reading List

Source URL: www.albertahealthservices.ca

Language: English - Date: 2013-09-16 18:32:42